OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001378624

Cellular Biomedicine Group, Inc.

Cellular Biomedicine Group, Inc. (CIK 0001378624, EIN 86-1032927) reported revenue of $339,920 for FY2019 (2019-01-01 to 2019-12-31) and net income of -$49.98 million (-$49,984,054) for FY2019 (2019-01-01 to 2019-12-31), as filed in its 10-K filed 2020-02-28 (accession 0001654954-20-002065).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001378624
EIN86-1032927
SIC industry code2836 Biological Products, (No Diagnostic Substances)
State or country of incorporationDE
Fiscal year endDecember 31
Filer categoryAccelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_1h212b9q0jw02dapk7fsr03m7h
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$339,920FY20192019-01-01 to 2019-12-3110-K2020-02-280001654954-20-002065Revenues
Net income-$49,984,054FY20192019-01-01 to 2019-12-3110-K2020-02-280001654954-20-002065NetIncomeLoss
Total assets$97,324,300FY2019as of 2019-12-3110-K2020-02-280001654954-20-002065Assets
Total liabilities$41,606,609FY2019as of 2019-12-3110-K2020-02-280001654954-20-002065Liabilities
Stockholders' equity$55,717,691FY2019as of 2019-12-3110-K2020-02-280001654954-20-002065StockholdersEquity
Operating cash flow-$39,649,983FY20192019-01-01 to 2019-12-3110-K2020-02-280001654954-20-002065NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$2.63 per shareFY20192019-01-01 to 2019-12-3110-K2020-02-280001654954-20-002065EarningsPerShareBasicAndDiluted
Shares outstanding19,355,292 sharesFY2019as of 2020-02-2410-K2020-02-280001654954-20-002065EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2010-2019, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20192019-01-01 to 2019-12-31$339,92010-K2020-02-280001654954-20-002065
RevenueFY20182018-01-01 to 2018-12-31$224,40310-K2020-02-280001654954-20-002065
RevenueFY20172017-01-01 to 2017-12-31$336,81710-K2020-02-280001654954-20-002065
RevenueFY20162016-01-01 to 2016-12-31$627,93010-K2019-02-190001654954-19-001756
RevenueFY20152015-01-01 to 2015-12-31$2,505,42310-K2018-03-050001654954-18-002152
RevenueFY20142014-01-01 to 2014-12-31$564,37710-K2017-03-130001654954-17-001934
RevenueFY20132013-01-01 to 2013-12-31$204,91410-K2016-03-140001354488-16-006531
RevenueFY20122012-01-01 to 2012-12-31$9,399,25610-K/A2013-08-140001354488-13-004493
RevenueFY20112011-01-01 to 2011-12-31$285,50010-K/A2013-08-140001354488-13-004493
Net incomeFY20192019-01-01 to 2019-12-31-$49,984,05410-K2020-02-280001654954-20-002065
Net incomeFY20182018-01-01 to 2018-12-31-$38,945,49210-K2020-02-280001654954-20-002065
Net incomeFY20172017-01-01 to 2017-12-31-$25,490,31010-K2020-02-280001654954-20-002065
Net incomeFY20162016-01-01 to 2016-12-31-$28,208,37610-K2019-02-190001654954-19-001756
Net incomeFY20152015-01-01 to 2015-12-31-$19,447,72110-K2018-03-050001654954-18-002152
Net incomeFY20142014-01-01 to 2014-12-31-$15,474,61110-K2017-03-130001654954-17-001934
Net incomeFY20132013-01-01 to 2013-12-31-$13,797,03310-K2016-03-140001354488-16-006531
Net incomeFY20122012-01-01 to 2012-12-31-$7,031,51910-K2014-04-150001354488-14-001924
Net incomeFY20112011-01-01 to 2011-12-31-$516,41410-K/A2013-08-140001354488-13-004493
  • Revenue for FY2012 was restated: first reported as $9,368,771 (accession 0001354488-13-001757, filed 2013-04-04).
  • Revenue for FY2011 was restated: first reported as $35,500 (accession 0001354488-13-001757, filed 2013-04-04).
  • Net income for FY2012 was restated: first reported as $9,357,455 (accession 0001354488-13-001757, filed 2013-04-04).
  • Net income for FY2011 was restated: first reported as -$766,414 (accession 0001354488-12-001544, filed 2012-03-30).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2020-11-092020-09-300001654954-20-012014cbmg_10q.htm
10-Q2020-08-122020-06-300001654954-20-008950cbmg_10q.htm
10-Q2020-05-062020-03-310001654954-20-004977cbmg_10q.htm
10-K2020-02-282019-12-310001654954-20-002065cbmg_10k.htm
10-Q2019-11-062019-09-300001654954-19-012421cbmg_10q.htm
10-Q2019-08-062019-06-300001654954-19-008900cbmg_10q.htm
10-Q2019-04-302019-03-310001654954-19-005054cbmg_10q.htm
10-K2019-02-192018-12-310001654954-19-001756cbmg_10k.htm
10-Q2018-11-062018-09-300001654954-18-012031cbmg_10q.htm
10-Q2018-08-072018-06-300001654954-18-008569cbmg_10q.htm
10-Q2018-05-072018-03-310001654954-18-004805cbmg_10q.htm
10-K2018-03-052017-12-310001654954-18-002152cbmg_10k.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001378624published by the sourcedata.sec.gov/submissions/CIK0001378624.json2026-10-21
Employer Identification Number (EIN) · US-EIN86-1032927published by the sourcedata.sec.gov/submissions/CIK0001378624.json2026-10-21

Former names

NameFromTo
EastBridge Investment Group Corp2006-10-312013-02-22

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001378624.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001378624.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001378624" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001378624/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001378624/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1378624"}

On SEC EDGAR

About this data